Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke

Fig. 3

Comparison of serum DIDO1-Abs, FOXJ2-Abs, and CPSF2-Abs levels between HDs and patients with acute myocardial infarction (AMI) and diabetes mellitus (DM). GST-DIDO1:1-275 (a), bFOXJ2-426 (d), and bCPSF2-607 (g) were used as antigens. Serum antibody levels in HDs and patients with AMI and type 2 DM were determined using AlphaLISA and are shown as box-whisker plots, as described in the legend of Fig. 2. The same results are summarized in Table 3. Responses to DIDO1-Abs (b, c), FOXJ2-Abs (e, f), and CPSF2-Abs (h, i) were also evaluated using ROC analysis, and summarized in Table 5

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us